LicianPro

Lantheus Holdings, Inc. ·

LNTH 8-K 2026-09-21

Lantheus Holdings, Inc. (LNTH) 8-K dated 2026-09-21 — accession 0001193125-26-396654.

Lantheus Holdings, Inc. (LNTH) is a drug manufacturers - specialty & generic company listed on US.

Lantheus Holdings, Inc. filed a 8-K on 2026-09-21. Accession 0001193125-26-396654.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LNTH revenue for 2025-12-31 was $1.54B. Net income was $233.6M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. LNTH currently screens at market cap $5.56B and trailing P/E 25.4.

Not investment advice. The LNTH SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr